< Back to news

Groupe Berkem considers merging its main subsidiaries to rationalize the Group’s structure

Press release

Blanquefort (France), June 21, 2023 – Groupe Berkem, a leading player in bio-based chemistry (ISIN code: FR00140069V2 – Ticker: ALKEM), announces today that it is considering merging its main subsidiaries, BERKEM, EUROLYO, LIXOL and ADKALIS, grouped together within their parent company BERKEM DEVELOPPEMENT (a wholly owned subsidiary of Groupe Berkem), according to a schedule currently being drawn up.

Read more